SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as community members discuss a potential short squeeze and a possible breakout to new highs, with some anticipating a surge towards $112K and beyond. Bullish sentiment seems to be fueled by observations of coins leaving exchanges and the anticipation of 'Uptober,' while bearish voices warn of a potential dump during the Asian session. The conversation also includes the impact of institutional investment and upcoming ETF approvals.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the community debates its recent price action and potential catalysts. Bullish sentiment revolves around anticipated institutional adoption, with some mentioning potential benefits from stablecoins and tokenization. Bearish arguments focus on technical indicators and macro headwinds, suggesting further downside risk.

JFB Construction Holdings is a commercial and residential real estate construction and development company, which engages in delivering services to commercial and residential markets. It operates through the following segments: Commercial Construction, Residential Construction, and Real Estate Development. The Commercial Construction segment includes all activities related to the construction of commercial properties. The Residential Construction segment focuses on the construction of residential properties including single-family homes and multi-family units. The Real Estate Development segment refers to the acquisition, development, and sale of real estate properties. The company was founded by Joseph F. Basille III on April 9, 2024 and is headquartered in Lantana, FL.

JFB Construction Holdings - Ordinary Shares - Class A

JFB is trending due to a recently announced private placement of approximately $44 million. The community is discussing the potential impact of this financing on the company's working capital and future opportunities, while also noting the deal's potentially dilutive effect with warrants being issued. Some traders are also watching for potential continuation of momentum.

"What's Updog?" is a Community Led token.

UpDog

UpDog is trending as community members connect over the classic "What's UpDog?" joke, with many referencing it in their messages. Some users highlight that it's been over a year since the token launched on Solana and encourage others to load up. The community also celebrates various other tokens trending alongside UpDog.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is trending as the community discusses its potential as a future dividend stock and a possible short squeeze, citing a high short interest. Bullish investors highlight the recent FDA approval of their needle-free epinephrine spray, neffy, and its potential to disrupt the epinephrine market. Some analysts see potential for further upside in share price in light of a strong buy rating.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MLTX is trending due to positive Phase 2 trial results for its drug sonelokimab in treating hidradenitis suppurativa, with the community discussing its potential as a best-in-class treatment. Bullish sentiment is fueled by raised price targets and speculation of a potential buyout, while some caution against overvaluation and an upcoming public offering. The stock's significant gains and potential for further upside are key talking points among investors.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. It operates through the OSS and OSS Europe segments. The company was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

OSS is trending as investors discuss its potential in AI edge computing, fueled by recent contract wins and partnerships, including a new agreement with Maris Tech. Community talking points include the company's small float, potential for significant growth, and comparisons to other AI and defense sector stocks. Bullish sentiment seems to be driven by expectations around future military contracts and the company's strategic positioning in the growing AI edge computing market.

Blockchain-on-Blockchain (BOB) is a new blockchain built on top of another blockchain called ICP. It's like a special layer on an existing system. BOB creates a secure digital record book that uses ICP's network for safety. BOB uses a system called 'proof-of-on-chain-work': You deploy your own smart contract (canister) at bob.fun. This program solves math problems (hashes). Main computers (mother nodes) give out these problems. Miners solve the problems and tell the mother node. If correct, the mother node adds a new block to the blockchain. The winning miner gets BOB tokens as a reward.

$BOB.X is trending, with community members highlighting its upcoming halving event and its potential as the 'Bitcoin of the Internet Computer' due to its limited supply and on-chain proof-of-work mechanism. Some users are noting its availability on multiple chains and increased swapping activity. The coin's association with $ICP.X and comparisons to $BTC.X are also key talking points.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as traders assess the potential impact of upcoming economic data and geopolitical events, particularly focusing on the possibility of government intervention to lower drug prices. Community members are actively debating technical indicators and potential trading strategies. Bullish and bearish sentiments are fluctuating amid uncertainty in the biotech sector.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors discuss its recent earnings and future prospects, particularly the QNX technology and its partnerships. Community members highlight the company's potential for growth in the cybersecurity and IoT sectors, viewing it as an undervalued play with a strong turnaround story. Discussions also include potential price targets and technical analysis, pointing to possible accumulation and breakout patterns.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

New Strong Sell Stocks for September 4th

DERM, HOPE and NXRT have been added to the Zacks Rank #5 (Strong Sell) List on September 4, 2025.

Journey Medical Corporation (DERM) Reports Q2 Loss, Beats Revenue Estimates

Journey Medical (DERM) delivered earnings and revenue surprises of -128.57% and +1.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Zevra, Inovio and Journey Medical are set for potential earnings beat this week, backed by strong products and positive ESP scores.

Journey Medical Corporation (DERM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Journey Medical (DERM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates

The Joint Corp. (JYNT) Reports Q1 Loss, Tops Revenue Estimates

Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Lags Revenue Estimates

What's Going On With Journey Medical Stock Today?

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.
read more...

Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights

Record consolidated net revenue of $84.5 million for full-year 2023 Fortress may receive up to four regulatory decisions on NDAs and BLAs in the next 18 months FDA accepted New Drug Application...

Journey Medical Co. (NASDAQ:DERM) Director Lindsay A. Md Rosenwald Acquires 10,000 Shares of Stock

Journey Medical Co. (NASDAQ:DERM  Get Free Report) Director Lindsay A. Md Rosenwald acquired 10,000 shares of Journey Medical stock in a transaction that occurred on Monday, March 25th. The...

Journey Medical Corp. is a commercial-stage pharmaceutical company, which focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Its brands include QBREXZA, Accutane, Targadox, AMZEEQ, Ximino, ZILXI, Exelderm, and Luxamend. The company was founded by Claude Maraoui in October 2014 and is headquartered in Scottsdale, AZ.

Journey Medical Corp

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

DERM
Journey Medical Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DERM News

DERM Journey Medical Corp